{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:34Z","timestamp":1707525634665},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,18]]},"DOI":"10.7759\/cureus.50742","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:22:50Z","timestamp":1702945370000},"source":"Crossref","is-referenced-by-count":0,"title":["How Should Complicated Cases of Thrombotic Thrombocytopenic Purpura With Positive Coombs Test Be Treated?"],"prefix":"10.7759","author":[{"given":"Moutaz","family":"Ghrewati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tala","family":"Beliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Zakharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehandar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2021.12.001","article-title":"Autoimmune hemolytic anemia: Diagnosis and differential diagnosis","volume":"36","author":"Scheckel CJ","year":"2022","unstructured":"Scheckel CJ, Go RS. Autoimmune hemolytic anemia: Diagnosis and differential diagnosis. Hematol Oncol Clin North Am. 2022, 36:315-24. 10.1016\/j.hoc.2021.12.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"96","author":"George JN","year":"2000","unstructured":"George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood. 2000, 96:1223-9.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V89.4.1224","article-title":"Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells","volume":"89","author":"Mitra D","year":"1997","unstructured":"Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood. 1997, 89:1224-34.","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake JL","year":"1982","unstructured":"Moake JL, Rudy CK, Troll JH, et al.. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982, 307:1432-5. 10.1056\/NEJM198212023072306","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2021.12.2.8","article-title":"Caplacizumab for acute thrombotic thrombocytopenic purpura","volume":"12","author":"Katsivalis KV","year":"2021","unstructured":"Katsivalis KV, Thomas J. Caplacizumab for acute thrombotic thrombocytopenic purpura. J Adv Pract Oncol. 2021, 12:211-5. 10.6004\/jadpro.2021.12.2.8","journal-title":"J Adv Pract Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely SK","year":"2003","unstructured":"Vesely SK, George JN, L\u00e4mmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003, 102:60-8. 10.1182\/blood-2003-01-0193","journal-title":"Blood"},{"key":"ref7","article-title":"Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis)","volume":"88","author":"Mannucci PM","year":"2003","unstructured":"Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica. 2003, 88:914-8.","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26068","article-title":"Coombs positive thrombotic thrombocytopenic purpura in a male pediatric patient: an urgent diagnostic challenge","volume":"63","author":"Zenno A","year":"2016","unstructured":"Zenno A, Richardson M. Coombs positive thrombotic thrombocytopenic purpura in a male pediatric patient: an urgent diagnostic challenge. Pediatr Blood Cancer. 2016, 63:1860-2. 10.1002\/pbc.26068","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000089469","article-title":"Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus","volume":"115","author":"Aleem A","year":"2006","unstructured":"Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Acta Haematol. 2006, 115:68-73. 10.1159\/000089469","journal-title":"Acta Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani FA","year":"2015","unstructured":"Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood. 2015, 125:3860-7. 10.1182\/blood-2014-11-551580","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study","volume":"89","author":"Balduini CL","year":"2010","unstructured":"Balduini CL, Gugliotta L, Luppi M, et al.. High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. Ann Hematol. 2010, 89:591-6. 10.1007\/s00277-009-0877-5","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01530.x","article-title":"Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006","volume":"48","author":"Nguyen L","year":"2008","unstructured":"Nguyen L, Li X, Duvall D, Terrell DR, Vesely SK, George JN. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008, 48:349-57. 10.1111\/j.1537-2995.2007.01530.x","journal-title":"Transfusion"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-559211","article-title":"The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura","volume":"125","author":"Lim W","year":"2015","unstructured":"Lim W, Vesely SK, George JN. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015, 125:1526-31. 10.1182\/blood-2014-10-559211","journal-title":"Blood"},{"key":"ref14","article-title":"Splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura?","volume":"53","author":"Dubois L","year":"2010","unstructured":"Dubois L, Gray DK. Splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura?. Can J Surg. 2010, 53:349-55.","journal-title":"Can J Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e328330f304","article-title":"Proteasome inhibition for antibody-mediated rejection","volume":"14","author":"Everly JJ","year":"2009","unstructured":"Everly JJ, Walsh RC, Alloway RR, Woodle ES. Proteasome inhibition for antibody-mediated rejection. Curr Opin Organ Transplant. 2009, 14:662-6. 10.1097\/MOT.0b013e328330f304","journal-title":"Curr Opin Organ Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008021","article-title":"A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP","volume":"137","author":"Coppo P","year":"2021","unstructured":"Coppo P, Bubenheim M, Azoulay E, et al.. A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP. Blood. 2021, 137:733-42. 10.1182\/blood.2020008021","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/210009-how-should-complicated-cases-of-thrombotic-thrombocytopenic-purpura-with-positive-coombs-test-be-treated","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:34Z","timestamp":1707509434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/210009-how-should-complicated-cases-of-thrombotic-thrombocytopenic-purpura-with-positive-coombs-test-be-treated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.50742","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}